Skip to main content
Premium Trial:

Request an Annual Quote

Drugs: Keep ‘Em Coming


New advances in therapeutics seem to be everywhere these days, and two new studies point to this encouraging progress.  One, a pilot study conducted by Duke University Medical Center, has found that in conjunction with another chemo drug, Avastin helps to shrink deadly brain tumors by cutting off their blood supply.  They found that together, the two drugs stopped tumor growth up to two times as long as other therapies.

In another study, a new drug candidate has been found to reduce the mental retardation associated with Down syndrome.  The researchers, whose results were published in yesterday’s Nature Neuroscience, used mice models that had two copies of chromosome 16.  For a crib notes version, ScienceBlogs blogger Shelley Batts wraps it up pretty well.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.